Message processing apparatus
    1.
    发明授权
    Message processing apparatus 失效
    消息处理装置

    公开(公告)号:US06934738B1

    公开(公告)日:2005-08-23

    申请号:US09522584

    申请日:2000-03-10

    摘要: A message processing apparatus which handles messages exchanged over a network and explicitly notifies the recipient of the importance and other information regarding each received message. Incoming messages are received by a receiver employed in the apparatus. Those messages may contain some key information as part of their attribute data, which specifies a handler program relevant to them. A key information extraction unit extracts the key information from each received message. Consulting a table that defines the relationships between handler programs and various key information, a program loading unit then loads a specific handler program relevant to the extracted key information. The recipient may cause an event related to the received message. Depending on what kind of event it is, an execution unit chooses and executes an appropriate primitive process provided as part of the handler program. When, for example, the recipient attempts to delete an unopened message, the apparatus will warn him/her by displaying a warning message on a monitor screen.

    摘要翻译: 一种消息处理设备,其处理通过网络交换的消息并且明确地通知接收者关于每个接收到的消息的重要性和其他信息。 接收到的消息由装置中采用的接收机接收。 这些消息可以包含一些关键信息作为其属性数据的一部分,其指定与它们相关的处理程序。 密钥信息提取单元从每个接收的消息中提取密钥信息。 咨询定义处理程序与各种关键信息之间关系的表,程序加载单元然后加载与提取的关键信息相关的特定处理程序。 收件人可能会导致与收到的邮件相关的事件。 根据事件的类型,执行单元选择并执行作为处理程序的一部分提供的适当的原语过程。 例如,当收件人尝试删除未打开的消息时,设备将通过在监视器屏幕上显示警告消息来警告他/她。

    Video presentation system
    2.
    发明授权
    Video presentation system 失效
    视频演示系统

    公开(公告)号:US5751296A

    公开(公告)日:1998-05-12

    申请号:US655449

    申请日:1996-05-30

    摘要: A video presentation system is provided which permits a process in which, when an object in motion video image is handled, an action relating to the object is executed, without increasing load on a central processing unit or a memory. Subject-of-operation information, which defines objects to be handled by a user in relation to each of frames of video data at a transitional phase of time-varying motion of each object, is stored in video operation information retaining means, and when a user operation takes place, the frame position of a currently reproduced video image is acquired from video driving/processing means while screen coordinates of the object are acquired from a coordinates specifying device. Based on the acquired data, video operation information processing means searches the subject-of-operation information to identify the object handled by the user. The subject-of-operation information retains only information associated with each transitional phase of motion of the object, whereby the size of information can be reduced, thus permitting the object specifying process and a like process to be executed at high speed.

    摘要翻译: 提供了一种视频呈现系统,其允许当处理运动中的对象物体时,执行与对象有关的动作,而不会增加中央处理单元或存储器的负担。 操作对象信息在每个对象的时变运动的过渡阶段中定义用户关于每个视频数据帧处理的对象,被存储在视频操作信息保存装置中,并且当一个 发生用户操作,当从坐标指定装置获取对象的屏幕坐标时,从视频驱动/处理装置获取当前再现的视频图像的帧位置。 基于获取的数据,视频操作信息处理装置搜索操作操作信息以识别用户处理的对象。 操作操作信息仅保留与对象的每个移动过渡阶段相关联的信息,从而可以减少信息的大小,从而允许以高速执行对象指定处理和类似过程。

    GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND USE THEREOF IN MEDICINES
    4.
    发明申请
    GLUCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND USE THEREOF IN MEDICINES 有权
    葡萄糖醛酰氧基吡唑衍生物及其在药物中的应用

    公开(公告)号:US20090093419A1

    公开(公告)日:2009-04-09

    申请号:US12169882

    申请日:2008-07-09

    IPC分类号: A61K31/7056

    摘要: The present invention provides glucopyranosyloxypyrazole derivatives represented by the general formula: wherein R represents a hydrogen atom, a lower alkyl group or a group forming a prodrug; one of Q and T represents a group represented by the general formula: (wherein P represents a hydrogen atom or a group forming a prodrug), while the other represents a lower alkyl group or a halo(lower alkyl) group; R2 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a lower alkylthio group, a halo(lower alkyl) group or a halogen atom; and with the proviso that P does not represent a hydrogen atom when R represents a hydrogen atom or a lower alkyl group, or pharmaceutically acceptable salts thereof, which exert an inhibitory activity in human SGLT2 and have an improved oral absorption, and therefore are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complications or obesity, and pharmaceutically acceptable salts thereof, and pharmaceutical uses thereof.

    摘要翻译: 本发明提供由以下通式表示的吡喃葡萄糖氧吡唑衍生物:其中R表示氢原子,低级烷基或形成前药的基团; Q和T之一表示由通式表示的基团:(其中P表示氢原子或形成前药的基团),而另一个表示低级烷基或卤代(低级烷基)基团; R2表示氢原子,低级烷基,低级烷氧基,低级烷硫基,卤代(低级烷基)或卤素原子; 并且条件是当R表示氢原子或低级烷基时,P不表示氢原子,或其药学上可接受的盐,其在人SGLT2中具有抑制活性并具有改善的口服吸收,因此可用作 用于预防或治疗与高血糖相关的疾病如糖尿病,糖尿病并发症或肥胖症的药剂及其药学上可接受的盐及其药学用途。

    Resin compostion and stretched film obtained by using the same
    5.
    发明申请
    Resin compostion and stretched film obtained by using the same 有权
    通过使用它们获得的树脂组合物和拉伸膜

    公开(公告)号:US20070032601A1

    公开(公告)日:2007-02-08

    申请号:US10572385

    申请日:2004-09-17

    IPC分类号: C08L23/04

    摘要: The present invention relates to a polyethylene-based stretched film having excellent Elmendorf tear strength and uniform stretchability. The invention relates to a polyethylene-based stretched film which is obtained by stretching a polyethylene-based resin, wherein (A-i) Em and Et, which represent the values of Elmendorf tear strength in the MD and TD directions, respectively, as measured in accordance with ASTM D1922, satisfy the following formulas 1, 2 and 3: 20≦Em[N/m]≦3000  (Formula 1) 20≦Et[N/m]≦3000  (Formula 2) 0.1≦(Em/Et)≦3  (Formula 3); (a-ii) the tensile initial modulus TM in the MD direction satisfies the following formula 4: 300≦TM[MPa]≦10000  (Formula 4); and (a-iii) the thickness is in the range of 5 to 150 μm, and is excellent in the stretch uniformity.

    摘要翻译: 本发明涉及具有优异的埃尔门多夫撕裂强度和均匀拉伸性的聚乙烯基拉伸膜。 本发明涉及通过拉伸聚乙烯类树脂而获得的聚乙烯基拉伸膜,其中(Ai)Em和Et分别代表根据MD和TD方向的埃尔曼多夫撕裂强度值 与ASTM D1922相符合下列公式1,2和3:<?in-line-formula description =“In-line formula”end =“lead”?> 20 <= Em [N / m] <= 3000 1)<?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-line formula”end =“lead”?> 20 <= Et [N / m] <= 3000(公式2)<?in-line-formula description =“In-line Formulas”end =“tail”?> <?in-line-formula description =“In-line Formulas”end =“铅”?> 0.1 <=(Em / Et)<= 3(式3); (a-ii)MD方向上的拉伸初始模量TM满足下列公式4:<?在线公式描述=“直线公式”end =“tail” =“在线公式”end =“lead”?> 300 <= TM [MPa] <= 10000(公式4); <?in-line-formula description =“In-line Formulas”end =“tail”?>和(a-iii)厚度在5至150μm的范围内,并且拉伸均匀性优异。

    Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
    6.
    发明授权
    Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof 失效
    吡喃葡萄糖氧基苄基苯衍生物,含有它们的药物组合物及其制备中间体

    公开(公告)号:US07053060B2

    公开(公告)日:2006-05-30

    申请号:US10432905

    申请日:2001-11-20

    CPC分类号: C07H15/203

    摘要: The present invention relates to glucopyranosyloxybenzylbenzene derivatives represented by the general formula: wherein R1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted (lower alkyl) group, a substituted or unsubstituted (lower alkoxy) group etc.; R2 represents a hydrogen atom or a lower alkyl group; and R3 represents a substituted or unsubstituted (lower alkyl) group, a substituted or unsubstituted (lower alkoxy) group, a substituted or unsubstituted (lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.

    摘要翻译: 本发明涉及由以下通式表示的吡喃葡萄糖氧基苄基苯衍生物:其中R 1表示氢原子,羟基,取代或未取代的氨基,氨基甲酰基,取代或未取代的(低级烷基 )基团,取代或未取代的(低级烷氧基)基团等; R 2表示氢原子或低级烷基; 和R 3表示取代或未取代的(低级烷基)基团,取代或未取代的(低级烷氧基)基团,取代或未取代的(低级烷硫基)等,或其药学上可接受的盐,其中 在人SGLT2中具有抑制活性,并且可用作预防或治疗与高血糖相关的疾病如糖尿病,糖尿病并发症或肥胖症的药剂,包含其的药物组合物及其中间体。

    Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof
    7.
    发明申请
    Glucopyranosyloxybenzylbenzene derivatives, medicinal compositions containing the same and intermediates in the production thereof 失效
    吡喃葡萄糖氧基苄基苯衍生物,含有它们的药物组合物及其制备中间体

    公开(公告)号:US20050059614A1

    公开(公告)日:2005-03-17

    申请号:US10978413

    申请日:2004-11-02

    CPC分类号: C07H15/203

    摘要: The present invention relates to glucopyranosyl-oxybenzylbenzene derivatives represented by the general formula: wherein R1 represents a hydrogen atom, a hydroxy group, a substituted or unsubstituted amino group, a carbamoyl group, a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group etc.; R2 represents a hydrogen atom or a lower alkyl group; and R3 represents a substituted or unsubstituted(lower alkyl) group, a substituted or unsubstituted(lower alkoxy) group, a substituted or unsubstituted(lower alkylthio) group etc., or pharmaceutically acceptable salts thereof, which have an inhibitory activity in human SGLT2 and are useful as agents for the prevention or treatment of a disease associated with hyperglycemia such as diabetes, diabetic complication or obesity, pharmaceutical compositions comprising the same and intermediates thereof.

    摘要翻译: 本发明涉及由以下通式表示的吡喃葡萄糖基 - 氧苄基苯衍生物:其中R 1表示氢原子,羟基,取代或未取代的氨基,氨基甲酰基,取代或未取代的(低级烷基) 取代或未取代的(低级烷氧基)等。 R 2表示氢原子或低级烷基; 和R 3表示具有抑制活性的取代或未取代的(低级烷基)基团,取代或未取代的(低级烷氧基)基团,取代或未取代的(低级烷硫基)等,或其药学上可接受的盐 人SGLT2,并且可用作预防或治疗与高血糖相关的疾病(如糖尿病,糖尿病并发症或肥胖症)的药剂,包含其的药物组合物及其中间体。

    Polyethylene resin composition for heavy-duty packaging bag and
polyethylene resin film produced from the same
    9.
    发明授权
    Polyethylene resin composition for heavy-duty packaging bag and polyethylene resin film produced from the same 失效
    用于重型包装袋和聚乙烯树脂膜的聚乙烯树脂组合物由其制成

    公开(公告)号:US5756193A

    公开(公告)日:1998-05-26

    申请号:US623147

    申请日:1996-03-28

    摘要: Disclosed is a polyethylene resin composition for heavy-duty packaging bag, which has a specific MFR, a specific density and a specific melt tension and which comprises (I) a linear low-density polyethylene resin prepared from ethylene and an .alpha.-olefin of 4 or more carbon atoms and having a specific MFR, a specific molecular weight distribution and a density of 0.900 to 0.918 g/cm.sup.3, (II) a linear medium or high-density polyethylene resin having a density of 0.935 to 0.970 g/cm.sup.3 and (III) a high-pressure low-density polyethylene resin having a density of 0.915 to 0.924 g/cm.sup.3, in a specific ratio of components. Also disclosed is a polyethylene resin film prepared from said composition. The composition is able to provide a film which is excellent in low-temperature properties such as low-temperature drop-bag strength and can be advantageously used for a heavy-duty packaging bag even in a cold district of below-freezing temperature. The polyethylene resin film exerts the above-mentioned effects.

    摘要翻译: 公开了一种用于重型包装袋的聚乙烯树脂组合物,其具有特定的MFR,比重密度和特定的熔体张力,并且包括(I)由乙烯和α-烯烃制备的线性低密度聚乙烯树脂 或更多的碳原子,并且具有特定的MFR,特定的分子量分布和0.900至0.918g / cm 3的密度,(II)密度为0.935至0.970g / cm3的线性介质或高密度聚乙烯树脂和( III)以特定比例的组分密度为0.915至0.924g / cm 3的高压低密度聚乙烯树脂。 还公开了由所述组合物制备的聚乙烯树脂膜。 该组合物能够提供低温下降袋强度等低温性能优异的膜,即使在低于冰点的低温区域也能够有利地用于重型包装袋。 聚乙烯树脂膜发挥上述效果。

    Visual communication terminal apparatus for performing multiplex
transmission of image and audio signals
    10.
    发明授权
    Visual communication terminal apparatus for performing multiplex transmission of image and audio signals 失效
    用于执行图像和音频信号的多路传输的视觉通信终端装置

    公开(公告)号:US5539811A

    公开(公告)日:1996-07-23

    申请号:US226591

    申请日:1994-04-12

    摘要: A visual communication is performed between a calling party and a called party through a plurality of channels. After the parties are connected through a first channel, an available telephone number of a second channel stored in a BAS control portion is read to a TNI control portion on each of the parties, and the TNI control portions of the parties exchange the available telephone numbers. Thereafter, when an incoming call having a telephone number is received through the second channel by a call control processing portion of the called party, the telephone number of the call is compared with the available telephone number of the second channel by an ICJ portion. To perform correct visual communication between parties, in cases where the telephone number of the call agrees with the available telephone number, the call is established by the call control processing portion, and image and audio signals are transmitted from the calling party to the called party through codec portions, multiplexing/demultiplexing portions and the first and second channels to perform a visual communication. In contrast, in cases where the telephone number of the call does not agree with the available telephone number, the second channel is released.

    摘要翻译: 通过多个信道在呼叫方和被叫方之间进行可视通信。 在通过第一信道连接各方之后,存储在BAS控制部分中的第二信道的可用电话号码被读取到每个方的TNI控制部分,并且各方的TNI控制部分交换可用的电话号码 。 此后,当通过被叫方的呼叫控制处理部分通过第二信道接收到具有电话号码的呼入时,通过ICJ部分将呼叫的电话号码与第二频道的可用电话号码进行比较。 为了在各方之间进行正确的视觉通信,在呼叫的电话号码与可用的电话号码一致的情况下,由呼叫控制处理部分建立呼叫,并且将图像和音频信号从呼叫方发送到被叫方 通过编解码部分,复用/解复用部分和第一和第二信道来执行视觉通信。 相反,在呼叫的电话号码与可用的电话号码不一致的情况下,第二频道被释放。